Primer: Gilead Sciences (GILD US) - Aug 2026
Gilead's dominance in the HIV market, led by blockbuster drugs like Biktarvy, provides a substantial and durable cash flow base, funding...
90 Views
Primer: Gilead Sciences (GILD UW) - Sep 2025
Gilead's durable and highly profitable HIV franchise, led by Biktarvy, provides a stable cash flow foundation, funding shareholder returns and...
154 Views